Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Cancer therapeutics and mechanisms, and Radiopharmaceutical Chemistry and Applications.
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Comprehensive genomic profiles of small cell lung cancer
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients
LUX-Lung 3: Redundancy, Toxicity or a Major Step Forward? Afatinib as Front-Line Therapy for Patients with Metastatic EGFR-Mutated Lung Cancer
Diarrhea associated with afatinib: an oral ErbB family blocker
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center